Thursday, December 08, 2022 12:25:09 PM
The Immune cells do the same thing with zinc atoms. But one must refuel the body with zinc.
"(paxlovid) works is it stops the virus from replicating itself. It doesn't kill the covid virus, it just halts its duplication thus giving the body's immune system a chance to go after it."
Regarding this:
"That's why if you wait too long (more than 3 days after symptoms) then it is usually too late for it to help that much. That's my understanding. It doesn't kill the virus, it just prevents it from reproducing itself."
The Immune system does not need Paxlovid after 3-5
Paxlovid gives the Immune system time to build up, manufacture the antibodies.
With an enemy (viruses) that enslaves human cells and turns them into viral factories, you must act asap to limit the enemies troop size...
"(paxlovid) works is it stops the virus from replicating itself. It doesn't kill the covid virus, it just halts its duplication thus giving the body's immune system a chance to go after it."
Regarding this:
"That's why if you wait too long (more than 3 days after symptoms) then it is usually too late for it to help that much. That's my understanding. It doesn't kill the virus, it just prevents it from reproducing itself."
The Immune system does not need Paxlovid after 3-5
Paxlovid gives the Immune system time to build up, manufacture the antibodies.
With an enemy (viruses) that enslaves human cells and turns them into viral factories, you must act asap to limit the enemies troop size...
Bullish
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
